BioFlash

San Francisco Business Times
  • 5,0 (3)
  • AFFAIRES

BioFlash is a biweekly podcast, hosted by San Francisco Business Times biotech reporter Ron Leuty. From cancer immunotherapy to drug pricing, we explore the hot topics driving the life sciences ecosystem in the San Francisco Bay Area and beyond.

Épisodes

  1. Where does drug pricing cross the line into gouging?

    15/01/2018

    Where does drug pricing cross the line into gouging?

    Big money was evident throughout the 36th J.P. Morgan Healthcare Conference — from the $200 an hour it costs to meet with someone in some hotel lobbies or lounges to the price of drugs. But as life-changing, one-shot-and-you're-done gene therapies emerge as options — with price tags approaching or exceeding $1 million — how much is too much?

    15 min
  2. The iPhone, blockchain and other health themes from Stanford Medicine Dean Lloyd Minor

    12/01/2018

    The iPhone, blockchain and other health themes from Stanford Medicine Dean Lloyd Minor

    Lloyd Minor, dean of the Stanford University School of Medicine, talks about the trends capturing health care and biotech. Lloyd Minor's list of three challenges that will define health care's future: https://www.linkedin.com/pulse/jpm-2018-three-challenges-define-health-cares-future-lloyd-minor/

    28 min
  3. From full-body scanners to new-age drugs, Mir Imran's passion for 'big, unsolved mysteries'

    09/01/2018

    From full-body scanners to new-age drugs, Mir Imran's passion for 'big, unsolved mysteries'

    Mir Imran developed an early defibrillator and those full-body scanners at airport security. After a career that's also included patents for medical devices, his Rani Therapeutics now is taking on new-age drugs designed to reduce side effects and increase efficacy.

    39 min
  4. How a venture fund weighs risk and spots scientific passion

    08/01/2018

    How a venture fund weighs risk and spots scientific passion

    Nick Naclerio oversaw many deals by life sciences tools maker Illumina Inc. Now he's heading up a $230 million fund, which takes its name from and includes Illumina as an investor.

    24 min
  5. How a startup is using machine learning to speed new Parkinson's, ALS drugs

    05/01/2018

    How a startup is using machine learning to speed new Parkinson's, ALS drugs

    Alice Zhang sees a way of tapping machine learning to accelerate the development of new drugs to treat Parkinson's disease and other brain diseases — and dismiss the ones that won't work.

    23 min
  6. What an emerging drug company is doing to disrupt depression

    02/01/2018

    What an emerging drug company is doing to disrupt depression

    Dr. Atul Mahableshwarkar, hired last summer by BlackThorn Therapeutics as vice president of clinical development, talks about the South San Francisco drug company's attack on depression.

    29 min
  7. How Glenn Close, Billy Crystal and a S.F. nonprofit are conquering the 'last frontier'

    20/10/2017

    How Glenn Close, Billy Crystal and a S.F. nonprofit are conquering the 'last frontier'

    Billy Crystal talks about the award he accepted from Bring Change To Mind, the mental health nonprofit cofounded by Glenn Close, while Close talks about eliminating the stigma of mental disorders and changing how mental health issues are discussed, diagnosed and treated.

    12 min
  • 7 épisodes

Notes et avis

5
sur 5
3 notes

À propos

BioFlash is a biweekly podcast, hosted by San Francisco Business Times biotech reporter Ron Leuty. From cancer immunotherapy to drug pricing, we explore the hot topics driving the life sciences ecosystem in the San Francisco Bay Area and beyond.

Informations

  • Création
    San Francisco Business Times
  • Années d’activité
    2016 - 2018
  • Épisodes
    7
  • Classification
    Tous publics
  • Copyright
    © All rights reserved
  • Site web de l’émission
    BioFlash